Open AccessViews and practices of community pharmacists regarding services for people with type 2 diabetes
Author(s) -
Abduelkarem Abduelmula R.,
Sackville Mike A.,
Morgan Rae M.,
Sackville Margaret P.,
Hildreth Anthony J.
Publication year - 2003
Publication title -
international journal of pharmacy practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.42
H-Index - 37
eISSN - 2042-7174
pISSN - 0961-7671
DOI - 10.1211/0022357021990
Subject(s) - medicine , pharmacist , family medicine , pharmacy , medical prescription , community pharmacist , type 2 diabetes , diabetes mellitus , promotion (chess) , community pharmacy , nursing , politics , political science , law , endocrinology
Objective To describe the views and practices of community pharmacists regarding services for people with type 2 diabetes. Method A cross‐sectional questionnaire survey of a convenience sample of 317 community pharmacists in the North East of England. The 26‐item questionnaire covered the setting of the pharmacy, dispensing medication, and the pharmacist's role in the primary prevention of diabetes, detecting undiagnosed diabetes and prevention of complications. Key findings There was a 51% response rate. More than 80% of respondents reported that they saw patients with diabetes “very often” or “often” when they collected their prescriptions, but three‐quarters reported that they “never/rarely” or only “sometimes” advised patients what to expect from their medication and gave information to help them have a better understanding of their disease. More than 90% of the pharmacists believed that a healthy lifestyle is important, but the majority were “never/rarely” or only “sometimes” involved in its promotion. Around 10 per cent of the respondents reported that they “often” or “very often” promoted regular eye examinations. Home blood glucose monitoring was promoted by 50% of the respondents. The majority reported that they checked prescriptions for drug interactions. Conclusion This study found that community pharmacists' advice and services to people with type 2 diabetes fell short of the standards and objectives set out in the National Service Framework for Diabetes. Our findings can be used to promote discussion in the profession and with stakeholders about the future role of the community pharmacist in diabetes care.